Daily Investment Strategy

2024.08.02 10:00

Hang Seng Index fell 39 points on Thursday

The Hang Seng Index fell 39 points or 0.2% to 17,304 on Thursday. HSTECH fell 40 points or 1.1% to 3,476 and HSCEI fell 20 points or 0.3% to 6,086. Daily market turnover was HK$94.1bn.

 

S&P 500 falls as weak economic data unsettles stocks

The S&P 500 opened under pressure on Thursday as weak economic data brought recession fears back into focus. The Dow Jones Industrial Average fell 669 points, or 1.6%, the S&P 500 fell 2.8%, and the Nasdaq fell 2.8%. Technology stocks followed the broader market lower, although Meta Platform rose nearly 5% on stronger-than-expected second-quarter earnings and upbeat guidance. The results suggest the company's investment in artificial intelligence to improve the effectiveness of its targeted ads is starting to bear fruit. Meanwhile, Qualcomm shares fell 9% as the U.S. revoked an export license for sanctioned Chinese telecoms firm Huawei, hurting its revenue. Meanwhile, chip designer Arm Holdings ADR fell about 16% after the company issued weaker guidance that offset better-than-expected quarterly results. NVIDIA Corporation shares fell nearly 7%, down from the previous day's gains, as investors awaited further news from the chip industry, with Intel set to report earnings after the close. Apple and Amazon are also due to report earnings on Thursday. Shares of drugmaker Moderna fell 21% after the company cut its full-year revenue forecast due to sluggish EU sales and fierce competition in the U.S. vaccine market. The company's shares plunged 11%. Shares of Eli Lilly rose 3% after trial results showed that the weight loss drug Zepbound can reduce the risk of hospitalization, death and other consequences in obese adults with a common form of heart failure.

 

Weak U.S. economic data sparks economic panic ahead of non-farm payrolls data

The initial jobless claim in the week of July 27 increased to 249,000, higher than expected, while the ISM manufacturing index in July was 46.8, lower than expected and lower than June's 48.5. The two reports heightened concerns about an economic downturn even as the Federal Reserve is expected to cut interest rates in September. The 10-year U.S. Treasury yield fell below 4% for the first time since February as concerns about an economic hard landing resurfaced.

Hong Kong Stock Connect had a net inflow of HK8.37bn on Thursday of which Tracker Fund (2800) had the largest net inflow, reaching HK$2.0bn; followed by HSCEI (2828). HSBC (5) recorded the largest net outflow at HK$0.28bn, followed by Shenhua (1088).

Recommended Stocks
Capture the moment and trade with KGI Asia's insights
Stocks
Recommended
Stocks
Recommended

Since CKI announced its plans for a secondary listing in the UK, its stock price has hit a 52-week high, reflecting the market's positive view of the news. In addition, the company benefited from the recently released draft decision on regulated water assets by the British Water Regulatory Authority (Ofwat). The dissipation of regulatory uncertainties will be good for Cheung Kong Infrastructure, which holds nearly 40% of the company. The Group’s financial position continued to be strong, with cash on hand of HKD13 billion and a net debt to net total capital of 7.7% by the end of 2023. The company, together with other strategic partners within the CK Group, including CK Asset and Power Assets, who are also very solid in their financials, are well placed to capitalize on investment opportunities, whether in its existing industries or new ones, as they arise around the globe. Target price: $57; Stop- Loss price: $50.

Wen Kit Kenny is a SFC licensed person accredited to KGI Group to carry on regulated activities (for details, please refer to:https://apps.sfc.hk/publicregWeb/indi/AJF244/details). He and/or his associate do not have any financial interest in the recommended issuer or new listing applicant.

The materials contained herein are provided by KGI Asia Limited ("KGI") for information only. While such materials are based on or derived from sources believed to be reliable, KGI makes no representation or warranty (express or implied) as to their accuracy or reliability. Neither the information nor the opinions expressed herein constitute, or are to be construed as, an offer or invitation or solicitation of an offer to buy or sell any securities or investments. KGI and its officers, employees, agents and affiliates may have interests in the securities or investments covered herein and accept no liability whatsoever for any loss or consequence whatsoever (whether direct or indirect) resulting from any use of or reliance by you on such materials.

Subscribe to KGI Market Insights Reports
Outperform market and make the best investment decisions